OrganaBio

Join us at Amoura in San Francisco for a relaxed and enjoyable happy hour with the OrganaBio team! Whether you're looking to chat about sourcing fresh/frozen HLA-typed apheresis materials for your upcoming projects or simply network with like-minded professionals, this event is for you. Come enjoy free food and drinks, make meaningful connections, and let's talk science! Don't miss out! RSVP now on LinkedIn to secure your spot and stay updated on event details. #Networking #CGT #SFO

OrganaBio is supporting cell therapy development with innovative solutions for consistent and scalable manufacturing. From research to commercialization, our frozen cellular materials help biopharma companies minimize risk, ensure reliability, and accelerate timelines. In our latest article, J. Dominic Mancini, Vice President of Operations, shares insights into how frozen cells are critical to the cell therapy landscape. Discover why frozen materials are the key to overcoming the challenges of donor variability, logistics, and scalability in cell therapy manufacturing. Read the full article to explore how OrganaBio supports developers with proactive, cost-effective solutions: https://lnkd.in/e7sEfYjv #Biopharma #Innovation #CellTherapy #Manufacturing #Biotechnology

We're #hiring a new Cell Processing Associate in Miami, Florida. Apply today or share this post with your network. #JobOpening #Hiring #CareerOpportunity #JoinUs

🎉We are excited to be a finalist for Phacilitate's Supply Chain Innovation Award during #AdvancedTherapiesWeek in Dallas, Texas from January 20 - 23, 2025! 🎉 Stop by OrganaBio's booth (#365) to connect with Justin Irizarry, CFA Marisa Reinoso J. Dominic Mancini Carlos Carballosa, Ph.D. #ATA25 #AdvancedTherapies #CGT #ATW25

🎉✨ Happy Holidays from OrganaBio! ✨🎉 As we wrap up another incredible year, we want to extend our heartfelt gratitude to our amazing community. Your support and collaboration have been the driving force behind our success. May this festive season bring you joy, peace, and wonderful moments with your loved ones. Here's to a bright and prosperous new year ahead! Warmest wishes, The OrganaBio Team   #HappyHolidays #OrganaBio #CommunityLove #Gratitude #NewYear2025 #HolidayCheer  

🌟 Exciting News! 🌟 We are thrilled to announce that the FDA has approved the first mesenchymal stromal cell (MSC) therapy for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD) in pediatric patients! This groundbreaking approval marks a significant milestone in the field of regenerative medicine and opens new doors for innovative treatments. https://lnkd.in/eH63UdNn At OrganaBio, we are proud to support the development of MSC therapies by offering high-quality MSCs sourced from both placenta and cord tissue. Our commitment to providing top-notch cellular materials ensures that developers have access to the best resources for advancing their therapeutic projects. Join us in celebrating this monumental achievement and explore how OrganaBio can help you bring your MSC therapies to life! #OrganaBio #MSCTherapy #FDAApproval #RegenerativeMedicine #PlacentaMSCs #CordTissueMSCs #InnovativeTherapies

🌟 Exciting News! 🌟 We are thrilled to announce that OrganaBio's very own Jakob Starzyk has co-authored an article published in the prestigious journal, Nature! The article, titled "Efficient non-viral immune cell engineering using circular single-stranded DNA-mediated genomic integration," explores groundbreaking advancements in immune cell engineering. https://lnkd.in/gH3pcfRn This innovative research, co-authored by Jakob Starzyk and a team of brilliant scientists, highlights the potential of circular single-stranded DNA (cssDNA) in achieving highly efficient and precise genomic integration. The study demonstrates the superior efficiency of cssDNA in targeted genome integration across various clinically relevant primary cell types, including T cells, NK cells, and iPSCs. Join us in congratulating Jakob and the entire research team for their remarkable contribution to the field of biotechnology! 🎉👏 #Research #Biotechnology #NatureJournal #ImmuneCellEngineering #Innovation #Science

We are attending the ASH Annual meeting in San Diego next week! Set up a time to chat with Marisa Reinoso and discuss your unique leukapheresis donor needs and get information on OrganaBio's highly recallable and reliable donor pool. Visit www.organabio.com to learn more.

Excited to be a finalist for Phacilitate's Supply Chain Innovation Award during Advanced Therapies Awards 2025! Stop by our booth (#365) during #ATW25 in Dallas to chat about our supply chain solutions for your #CGT needs. #ATA25 #innovation #cellandgenetherapy

Thank you Mike O'Gorman and Life Science Marketplace! Excited to join and be a member!